LYRA
Lyra Therapeutics Inc.
$5.76
+$0.24(+4.35%)
30
Overall
40
Value
18
Tech
34
Quality
Market Cap
$9.77M
Volume
13.66K
52W Range
$3.81 - $37.50
Target Price
$11.50
Key Metrics Overview
| Market Cap | $9.77M | P/E Ratio | N/A |
| 52W High | $37.50 | 52W Low | $3.81 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 79.6% | 52W Position | 5.8% |
| Overall Score | 30 | Value Score | 40 |
| Quality Score | 34 | Technical Score | 18 |
Growth Analysis
| EPS Current Est | $-18.46 | EPS Next Est | $-6.64 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYRA | $5.76 | +4.3% | 13.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |